| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | Jun 30, 2025 | ACTUATE THERAPEUTICS, INC. | Director | Buy | 75.0 | +71,428 | 0.71% | ✗ | $500K |
| Jun 13, 2025 | Jun 13, 2025 | Lantern Pharma Inc. | 10% Owner | Sell | 22.5 | -40,000 | -3.58% | ✗ | $123.6K |
| Jun 10, 2025 | Jun 13, 2025 | Lantern Pharma Inc. | 10% Owner | Sell | 22.5 | -61,613 | -5.23% | ✗ | $208.3K |
| May 27, 2025 | May 29, 2025 | Lantern Pharma Inc. | 10% Owner | Sell | 22.5 | -56,237 | -4.56% | ✗ | $168.4K |
| Aug 14, 2024 | Aug 20, 2024 | ACTUATE THERAPEUTICS, INC. | Director | Sell | 22.5 | -24,999 | -1.74% | ✗ | $200K |
| Aug 14, 2024 | Aug 14, 2024 | ACTUATE THERAPEUTICS, INC. | Director | Buy | 100.0 | +475,001 | 20.46% | ✗ | $3.8M |
| May 23, 2024 | May 28, 2024 | Lantern Pharma Inc. | 10% Owner | Sell | 22.5 | -30,000 | -2.37% | ✗ | $189.1K |
| Feb 27, 2024 | Feb 29, 2024 | Lantern Pharma Inc. | 10% Owner | Sell | 20.0 | -144,000 | -10.23% | ✗ | $676.3K |
| Jan 17, 2024 | Jan 19, 2024 | Lantern Pharma Inc. | 10% Owner | Sell | 22.5 | -58,889 | -4.02% | ✗ | $247.3K |
| Nov 29, 2023 | Dec 1, 2023 | Lantern Pharma Inc. | 10% Owner | Sell | 20.0 | -145,348 | -9.48% | ✗ | $500K |
| Nov 8, 2022 | Nov 9, 2022 | Lantern Pharma Inc. | 10% Owner | Sell | 17.5 | -350,000 | -18.85% | ✗ | $1.5M |
| Sep 2, 2022 | Sep 7, 2022 | Lantern Pharma Inc. | 10% Owner | Sell | 43.8 | -6,445 | -0.34% | ✗ | $33.5K |